Retroperitoneal soft tissue sarcomas: Prognosis and treatment of primary and recurrent disease in 117 patients

Anticancer Research

Volumn 26, Issue 2 B, 2006, Pages 1577-1581

  Alldinger, Ingo ^a,b   Yang, Qin ^b   Pilarsky, Christian ^a   Saeger, Hans Detlev ^a   Knoefel, Wolfram T ^b,c   Peiper, Matthias ^b,c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Retroperitoneal; Soft tissue sarcoma; Surgery; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL SARCOMA; RETROPERITONEUM; SOFT TISSUE SARCOMA;

CHEMOTHERAPY, ADJUVANT; FEMALE; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NERVE SHEATH NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROPERITONEAL NEOPLASMS; SARCOMA;

EID: 33645815721     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Malerba M et al: Primary retroperitoneal soft tissue sarcomas: results of aggressive surgical treatment. World J Surg 23(7): 670-675, 1999.
2. Bautista N, Su W and O'Connell TX: Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease. Am Surg 66(9): 832-836, 2000.
3. Wittekind C, Bootz F and Meyer HJ: TNM, Klassifikation maligner Tumoren. Springer Verlag, Berlin, 2003.
4. Kaplan E and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 55: 457-481, 1958.
5. Walker S and Duncan D: Estimation of the probability of an event as a function of several independent variables. Biometrika 54: 167-179, 1967.
6. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
7. Cox D: Regression models and life-labels (with discussion). J R Stat Soc (B) 34: 187-220, 1972.
8. Peiper M et al: Survival in patients with primary soft-tissue sarcomas treated within 6 years. J Cancer Res Clin Oncol 124(3-4): 199-206, 1998.
9. Pirayesh A et al: The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature. Eur J Surg Oncol 27(5): 491-497, 2001.
10. Zornig C, Peiper M and Schroder S: Re-excision of soft tissue sarcoma after inadequate initial operation. Br J Surg 82(2): 278-279, 1995.
11. Gronchi A et al: Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 100(11): 2448-2455, 2004.
12. McGinn CJ: The role of radiation therapy in resectable retroperitoneal sarcomas. Surg Oncol 9(2): 61-65, 2000.
13. Gilbeau L et al: Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol 65(3): 137-143, 2002.
14. Rossi CR et al: Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer 100(9): 1943-1950, 2004.
15. Sindelar WF et al: Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 128(4): 402-410, 1993.
16. Bussieres E et al: Retroperitoneal soft tissue sarcomas: a pilot study of intraoperative radiation therapy. J Surg Oncol 62(1): 49-56, 1996.
17. Harris R and Lohr KN: Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137(11): 917-929, 2002.
18. Stoeckle E et al: Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 92(2): 359-368, 2001.
19. Potti A et al: Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas. Anticancer Res 24(1): 333-337, 2004.
20. Peiper M et al: CD44s expression is associated with improved survival in soft tissue sarcoma. Anticancer Res 24(2C): 1053-1056, 2004.